Resumen de Anti�Laminin-332 Mucous Membrane Pemphigoid Developing After a Diphtheria Tetanus Vaccination
Tanya Sezin, Ella Egozi, Wissam Hillou, Emily Avitan-Hersh, Reuven Bergman
Importance Bullous pemphigoid (BP) has been previously described to develop after vaccination in 26 patients. Immunoblotting or enzyme-linked immunosorbent assays (ELISAs), which were performed for 7 of these patients, have always shown circulating autoantibodies against BP180 and/or BP230 antigens. A case of anti�laminin-332 mucous membrane pemphigoid (MMP) that developed shortly after a diphtheria tetanus vaccination is described, with a review of the literature on postvaccination BP.
Observations A 29-year-old man developed an acute eruption of oral and cutaneous blisters and erosions 2 days after receiving a diphtheria tetanus vaccination. The histopathological, immunohistochemical, immunofluorescent, ELISA, and immunoblotting assay results were compatible with anti�laminin-332 MMP. The serum autoantibodies reacted with the ?3 and ?3 subunits of laminin-332. The disease was controlled by administering a combination of glucocorticosteroids and dapsone.
